SLDB FY 2023 Earnings — Solid Biosciences Inc. Revenue & Financial Results | Market Cap Arena

SLDBSolid Biosciences Inc.

$644M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$3M

Operating Income

-$104M

Net Income

-$96M

EPS (Diluted)

$-4.83

Cash Flow

Operating Cash Flow

-$94M

Free Cash Flow

-$96M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$165M

Total Liabilities

$38M

Stockholders' Equity

$126M

Cash & Equivalents

$74M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$8M	-100.0%
Gross Profit	-$3M	$8M	-131.9%
Operating Income	-$104M	-$106M	+2.0%
Net Income	-$96M	-$86M	-11.7%